Coronary Artery Disease (CAD) is the narrowing or blockage of the arteries that supply blood to the heart, affecting 16.5 million Americans. CAD is the leading cause of death in men and women, with a heart attack reported every 40 seconds in the United States.
RCE alleviates the patient-clinician-caregiver concern with our AI based technology that continuously monitors cardiac protein levels and changes in ECG patterns. Our non-invasive wearables seamlessly integrate into lifestyle, enabling good adherence and reliable patient-centric care.
RCE exhibits early clinical feasibility for detecting silent ischemia at the 2019 American Diabetes Association HealthTech Showcase
RCE is excited to join the Advanced Technology Development Center (ATDC) accelerate program, Georgia Tech’s startup incubator
RCE wins the 2019 SEMDA PitchRounds competition and works towards bringing a valuable diagnostic solution to market